Target
Beta-arrestin-1
Ligand
BDBM85035
Substrate
n/a
Ki
0.55±n/a nM
Comments
PDSP_1436
Citation
 Schotte, AJanssen, PFGommeren, WLuyten, WHVan Gompel, PLesage, ASDe Loore, KLeysen, JE Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 124:57-73 (1996) [PubMed]  Article 
Target
Name:
Beta-arrestin-1
Synonyms:
ARRB1 | ARRB1_RABIT | Beta-arrestin-1 | Cholinergic, muscarinic | OPIATE Delta | PAF Platelet activating factor
Type:
Enzyme Catalytic Domain
Mol. Mass.:
46360.54
Organism:
RABBIT
Description:
Cholinergic, muscarinic 0 RABBIT::Q95223
Residue:
410
Sequence:
MGDKGTRVFKKASPNGKLTVYLGKRGFVDHIDLVDPVDGVVLVDPEYLKERRVYVTLTCAFRYGREDLDVLGLTFRKDLFVANVQSFPPAPEDKKPLTRLQERLIKKLGEHAYPFTFEIPPKLPCSVTLQPGPEDTGKACGVDYEVKAFCAENLEEKIHKRNSVRLVIRKVQYAPERPGPHPTAETTRLFLMSDKPLHLEASLDKEIYYHGEPIIVNVHVTNNTNKTVKKIKISVRQYADICLFNTAQYKCPVAMEEADDTVAPSSTFCKVYTLTPFLANNREKRGLALDGKLKHEDTNLASSTLMREGANREILGIIVSYKVKVKLVVSRGGDVAVELPFTLMHPKPKEEPPHREVPENETPVDTNLIELDTNDDDIVFEDFARQRLKGMKDDKEEEDDVTGSPRLNDR
  
Inhibitor
Name:
BDBM85035
Synonyms:
CAS_65154-06-5 | PAF | bloodplatelet-activatingfactor
Type:
Small organic molecule
Emp. Form.:
C26H54NO7P
Mol. Mass.:
523.6832
SMILES:
CCCCCCCCCCCCCCCCOC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(C)=O |r|
Structure:
Search PDB for entries with ligand similarity: